MX9603484A - Derivados de 4-amino de acido micofenolico 5-sustituido. - Google Patents

Derivados de 4-amino de acido micofenolico 5-sustituido.

Info

Publication number
MX9603484A
MX9603484A MX9603484A MX9603484A MX9603484A MX 9603484 A MX9603484 A MX 9603484A MX 9603484 A MX9603484 A MX 9603484A MX 9603484 A MX9603484 A MX 9603484A MX 9603484 A MX9603484 A MX 9603484A
Authority
MX
Mexico
Prior art keywords
mycophenolic acid
amino derivatives
substituted mycophenolic
substituted
formula
Prior art date
Application number
MX9603484A
Other languages
English (en)
Inventor
Dean R Artis
Todd R Elworthy
Ronald C Hawley
David G Loughhead
David J Morgans Jr
Peter H Nelson
John W Patterson Jr
Eric B Sjogren
David B Smith
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of MX9603484A publication Critical patent/MX9603484A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)

Abstract

Los derivados de ácido micofenolico de la formula (IE) dados a conocer, son agentes terapéuticos convenientes en el tratamiento de enfermedades para la cuales se indica el ácido micofenolico y/o el micofenolato mofetil y otros agentes inmunopresores. En dicha formula, Z es una cadena lateral seleccionada a partir de las formulas (ZA, ZB, ZC, ZD, ZE, ZF, ZG y ZH).
MX9603484A 1994-02-18 1995-02-16 Derivados de 4-amino de acido micofenolico 5-sustituido. MX9603484A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/198,732 US5512568A (en) 1994-02-18 1994-02-18 Method of using 4-amino derivatives of 5-substituted mycophenolic acid
PCT/US1995/001786 WO1995022537A2 (en) 1994-02-18 1995-02-16 4-amino derivatives of 5-substituted mycophenolic acid

Publications (1)

Publication Number Publication Date
MX9603484A true MX9603484A (es) 1998-01-31

Family

ID=22734572

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9603484A MX9603484A (es) 1994-02-18 1995-02-16 Derivados de 4-amino de acido micofenolico 5-sustituido.

Country Status (22)

Country Link
US (2) US5512568A (es)
EP (1) EP0745072B1 (es)
JP (1) JPH09509173A (es)
CN (1) CN1141039A (es)
AT (1) ATE165826T1 (es)
AU (1) AU1875395A (es)
BR (1) BR9506838A (es)
CA (1) CA2183531A1 (es)
CO (1) CO4340732A1 (es)
DE (1) DE69502380T2 (es)
DK (1) DK0745072T3 (es)
ES (1) ES2116078T3 (es)
FI (1) FI963220A7 (es)
HK (1) HK1010784A1 (es)
IL (1) IL112666A (es)
LV (1) LV12149B (es)
MX (1) MX9603484A (es)
PH (1) PH31426A (es)
SI (1) SI0745072T1 (es)
TW (1) TW438788B (es)
WO (1) WO1995022537A2 (es)
ZA (1) ZA951293B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6514979B1 (en) 1999-03-03 2003-02-04 University Of Maryland Biotechnology Institute Synergistic combinations of guanosine analog reverse transcriptase inhibitors and inosine monophosphate dehydrogenese inhibitors and uses therefor
US6811998B2 (en) * 1999-06-25 2004-11-02 Roche Diagnostics Operations, Inc. Conjugates of uncompetitive inhibitors of inosine monophosphate dehydrogenase
US20050187170A1 (en) * 2003-06-16 2005-08-25 Biocryst Pharmaceuticals, Inc. Enhancing the efficiency of RNA polymerase inhibitors by using inosine monophosphate dehydrogenase inhibitors
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
WO2017210262A1 (en) 2016-06-02 2017-12-07 Steven Baranowitz Prevention and treatment of viral infections
US12011429B2 (en) 2016-06-02 2024-06-18 Steven Baranowitz Prevention and treatment of viral infections
US10603299B2 (en) 2016-06-02 2020-03-31 Steven Baranowitz Prevention and treatment of viral infections

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3825571A (en) * 1971-07-31 1974-07-23 Chugai Pharmaceutical Co Ltd Mycophenolic acid derivatives
JPS5542995B2 (es) * 1972-02-24 1980-11-04
JPS5529994B2 (es) * 1972-03-02 1980-08-07
US4686234A (en) * 1985-11-27 1987-08-11 Syntex (U.S.A) Inc. Mycophenolic acid derivatives in the treatment of inflammatory diseases, in particular rheumatoid arthritis
US4959387A (en) * 1986-01-23 1990-09-25 Syntex (U.S.A.) Inc. Mycophenolic acid derivatives in the treatment of rheumatoid arthritis
US4725622A (en) * 1986-01-23 1988-02-16 Syntex (U.S.A.) Inc. Mycophenolic acid derivatives in the treatment of rheumatoid arthritis
US4753935A (en) * 1987-01-30 1988-06-28 Syntex (U.S.A.) Inc. Morpholinoethylesters of mycophenolic acid and pharmaceutical compositions
US4727069A (en) * 1987-01-30 1988-02-23 Syntex (U.S.A.) Inc. Heterocyclic aminoalkyl esters of mycophenolic acid, derivatives thereof and pharmaceutical compositions
US4861776A (en) * 1987-01-30 1989-08-29 Syntex (U.S.A) Inc. Heterocyclic aminoalkyl esters of mycophenolic acid and derivatives thereof, compositions and use
US4748173A (en) * 1987-01-30 1988-05-31 Syntex (U.S.A.) Inc. Heterocyclic aminoalkyl esters of mycophenolic acid and derivatives thereof and pharmaceutical compositions
JPH0637486B2 (ja) * 1988-05-18 1994-05-18 三共株式会社 新規抗生物質フタレキシンおよびその製造法
US5247083A (en) * 1992-07-10 1993-09-21 Syntex (U.S.A.) Inc. Direct esterification of mycophenolic acid
US5380879A (en) * 1994-02-18 1995-01-10 Syntex (U.S.A.) Inc. Derivatives of mycophenolic acid

Also Published As

Publication number Publication date
CN1141039A (zh) 1997-01-22
EP0745072B1 (en) 1998-05-06
LV12149A (lv) 1998-10-20
DE69502380D1 (de) 1998-06-10
FI963220A0 (fi) 1996-08-16
PH31426A (en) 1998-10-29
ZA951293B (en) 1996-08-16
CO4340732A1 (es) 1996-07-30
FI963220A7 (fi) 1996-10-16
WO1995022537A2 (en) 1995-08-24
DK0745072T3 (da) 1999-01-18
US5538969A (en) 1996-07-23
IL112666A (en) 2000-01-31
IL112666A0 (en) 1995-05-26
EP0745072A1 (en) 1996-12-04
LV12149B (en) 1998-12-20
CA2183531A1 (en) 1995-08-24
HK1010784A1 (en) 1999-06-25
JPH09509173A (ja) 1997-09-16
ATE165826T1 (de) 1998-05-15
ES2116078T3 (es) 1998-07-01
WO1995022537A3 (en) 1995-10-26
BR9506838A (pt) 1997-09-30
AU1875395A (en) 1995-09-04
DE69502380T2 (de) 1998-10-08
TW438788B (en) 2001-06-07
SI0745072T1 (en) 1998-10-31
US5512568A (en) 1996-04-30

Similar Documents

Publication Publication Date Title
ZA951292B (en) 4-amino derivatives of mycophenolic acid
PH31406A (en) 6-Substituted mycophenolic acid and derivatives.
HU9600834D0 (en) Quinazoline derivatives
MX9603484A (es) Derivados de 4-amino de acido micofenolico 5-sustituido.
MX9700807A (es) Derivados de 3-azabiciclo (3.2.0)heptano n-sustituidos utiles como neurolepticos.
TW427986B (en) 4-amino 6-substituted mycophenolic acid and derivatives
MX9603483A (es) Acido micofenolico 6-sustituido y derivados.

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees